ResearcherShandong UniversityActive in the last 2 years
Zhen Li
Matched on ORCID iD 0000-0002-9783-169X; OpenAlex author ID A5100332644. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- Microbial variations in the multibody sites of the pancreatic ductal adenocarcinoma patients. Last author DOI 10.1097/js9.0000000000003799↗
- Integrative analysis of pancreatic microbiota and metabolome in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41598-025-27942-6↗
- Succession of the multi-site microbiome along pancreatic ductal adenocarcinoma tumorigenesis. Last author DOI 10.3389/fimmu.2024.1487242↗
- Von Hippel-Lindau syndrome with pancreatic adenocarcinoma (with videos). Co-author DOI 10.4103/eus-d-20-00213↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yiqing Zhu · 3 shared papers, 2024–2026 · strength 0.72
- Paper Microbial variations in the multibody sites of the pancreatic ductal adenocarcinoma patients. DOI 10.1097/js9.0000000000003799↗
- Paper Integrative analysis of pancreatic microbiota and metabolome in patients with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-025-27942-6↗
- Paper Succession of the multi-site microbiome along pancreatic ductal adenocarcinoma tumorigenesis. DOI 10.3389/fimmu.2024.1487242↗
- Xiao Liang · 3 shared papers, 2024–2026 · strength 0.72
- Paper Microbial variations in the multibody sites of the pancreatic ductal adenocarcinoma patients. DOI 10.1097/js9.0000000000003799↗
- Paper Integrative analysis of pancreatic microbiota and metabolome in patients with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-025-27942-6↗
- Paper Succession of the multi-site microbiome along pancreatic ductal adenocarcinoma tumorigenesis. DOI 10.3389/fimmu.2024.1487242↗
- Jianwei Xu · 1 shared paper, 2025 · strength 0.24
- Feng Li · 1 shared paper, 2025 · strength 0.24
- Yifan Wang · 1 shared paper, 2025 · strength 0.24
- Peng Wang · 1 shared paper, 2024 · strength 0.20
- Qingqing Qi · 1 shared paper, 2021 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.